Table 1. Demographic and baseline clinical data.
Characteristic | Population (N = 256) | Hyperglycemia group (n = 96) | Euglycemia group (n = 160) | P-value |
Age ± SD (years) | 55 ± 11 | 55 ± 10 | 54 ± 12 | 0.30 |
Gender ratio, male (%)/female (%) | 196 (76.5%)/ 60 (23.5%) | 75 (78.13%)/ 21 (21.87%) | 121 (75.63%)/ 39 (24.37%) | 0.03/0.76 |
Hypertension (%) | 86 (29.7%) | 36 (37.5%) | 50 (31.25%) | 0.37 |
Diabetes (%) | 92 (35.93%) | 72 (75%) | 20 (12.5%) | 0.0001 |
Smoker (%) | 168 (65.6%) | 54 (56.25%) | 104 (65.0%) | 0.20 |
History of CAD (%) | 30 (11.7%) | 12 (12.5%) | 18 (11.25%) | 0.92 |
Heart failure on admission (%) | 57 (22.26%) | 27 (28.12%) | 30 (18.75%) | 0.11 |
Cardiogenic shock (%) | 5(1.9%) | 2 (2.08%) | 3 (1.8%) | 0.72 |
Acute renal failure (%) | 24 (9.3%) | 13(13.54%) | 11 (6.8%) | 0.11 |